Difference between revisions of "Theranos"
| Line 1: | Line 1: | ||
[[File:Theranos_Logo.jpg|400px|thumb|right]] | [[File:Theranos_Logo.jpg|400px|thumb|right]] | ||
| − | == | + | == History == |
=== Elizabeth Holmes === | === Elizabeth Holmes === | ||
| Line 9: | Line 9: | ||
Holmes attended Stanford University in 2002 where she studied chemical engineering and worked in a laboratory as a student researcher in the School of Engineering (source a). At the end of freshman year, she worked in the Genome Institute of Singapore; at the lab she collected samples of blood with syringes to test for severe acute respiratory syndrome coronavirus (SARS-CoV-1) (source b). Seeing the great amount of blood needed to test for this diseased prompted Holmes to take action and seek to improve blood testing processes (source b). | Holmes attended Stanford University in 2002 where she studied chemical engineering and worked in a laboratory as a student researcher in the School of Engineering (source a). At the end of freshman year, she worked in the Genome Institute of Singapore; at the lab she collected samples of blood with syringes to test for severe acute respiratory syndrome coronavirus (SARS-CoV-1) (source b). Seeing the great amount of blood needed to test for this diseased prompted Holmes to take action and seek to improve blood testing processes (source b). | ||
| + | === Founding === | ||
| + | While at Stanford University, Elizabeth Holmes came up with the idea of developing a technology in the form of a patch that could adjust the dosage of a drug delivery and notify doctors of variables in patients’ blood (souce a). Her goal was to build a company that would make blood test available directly to consumers and eliminate the need for large needles and tubes of blood. She started developing lab-on-chip technology for blood tests and claimed to have developed a technology that could run more than 200 tests from just a few drops of blood (source b). In 2003, Holmes dropped out of Stanford and founded the company “Real-Time Cures” which later became Theranos, derived from the words “therapy” and “diagnosis” (source c). | ||
| − | |||
=== Partnerships/Investors === | === Partnerships/Investors === | ||
=== Timeline === | === Timeline === | ||
Revision as of 21:52, 25 January 2022
Contents
History
Elizabeth Holmes
Elizabth Holmes, born February 3, 1984, is an American former biotechnology entrepreneur who founded Theranos in 2003 at the age of 19. Holmes was born in Washington, D.C. to her dad Christian Holmes an entrepreneur who started an energy company called Enron then moving to the government agency USAID and her mom Noel, a Congressional committee staffer (source c).
Holmes attended Stanford University in 2002 where she studied chemical engineering and worked in a laboratory as a student researcher in the School of Engineering (source a). At the end of freshman year, she worked in the Genome Institute of Singapore; at the lab she collected samples of blood with syringes to test for severe acute respiratory syndrome coronavirus (SARS-CoV-1) (source b). Seeing the great amount of blood needed to test for this diseased prompted Holmes to take action and seek to improve blood testing processes (source b).
Founding
While at Stanford University, Elizabeth Holmes came up with the idea of developing a technology in the form of a patch that could adjust the dosage of a drug delivery and notify doctors of variables in patients’ blood (souce a). Her goal was to build a company that would make blood test available directly to consumers and eliminate the need for large needles and tubes of blood. She started developing lab-on-chip technology for blood tests and claimed to have developed a technology that could run more than 200 tests from just a few drops of blood (source b). In 2003, Holmes dropped out of Stanford and founded the company “Real-Time Cures” which later became Theranos, derived from the words “therapy” and “diagnosis” (source c).
